Literature DB >> 10798861

Towards a synthetic pneumococcal vaccine: synthetic oligosaccharides as tools for improving the specificity of enzyme-linked immunosorbent assays.

H Snippe, W T Jansen, J P Kamerling, D J Lefeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10798861      PMCID： PMC95872          DOI： 10.1128/CDLI.7.2.325-325.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  6 in total

1.  Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic.

Authors:  X Yu; Y Sun; C Frasch; N Concepcion; M H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.

Authors:  E Alonso de Velasco; A F Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

3.  beta-1,4-Galactosyltransferase-catalyzed synthesis of the branched tetrasaccharide repeating unit of Streptococcus pneumoniae type 14.

Authors:  J Niggemann; J P Kamerling; J F Vliegenthart
Journal:  Bioorg Med Chem       Date:  1998-09       Impact factor: 3.641

4.  Synthesis of four spacer-containing 'tetrasaccharides' that represent four possible repeating units of the capsular polysaccharide of Streptococcus pneumoniae type 6B.

Authors:  M J Thijssen; M H Bijkerk; J P Kamerling; J F Vliegenthart
Journal:  Carbohydr Res       Date:  1998-01       Impact factor: 2.104

5.  Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.

Authors:  E Alonso de Velasco; A F Verheul; G H Veeneman; L J Gomes; J H van Boom; J Verhoef; H Snippe
Journal:  Vaccine       Date:  1993-11       Impact factor: 3.641

6.  Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.

Authors:  E Alonso De Velasco; B A Dekker; A F Verheul; R G Feldman; J Verhoef; H Snippe
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226
  6 in total
  1 in total

1.  Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Authors:  W T Jansen; S Hogenboom; M J Thijssen; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe; A F Verheul
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.